Pronexus Analytical AB is a preclinical contract research organization (CRO) offering advanced services and collaborative projects in CNS pharmacology, neurochemistry and neurophysiology. Pronexus core expertise is focused on in vivo monitoring and screening tests using microdialysis and biosensor techniques in disease models, PK/PD studies, evaluation of implantable medical devices and drug delivery systems, as well as, the allied bioanalytical services. Our mission is to serve pharmaceutical companies and research organizations aiming to accelerate the process of drug discovery, evaluate mechanisms of drug actions and strengthen functional validation of candidate drugs.

October 30, 2009, Stockholm Pronexus Analytical exhibited at the Society for Neuroscience 39th Annual Meeting in Chicago, IL, October 17-21, 2009, the booth number 1714